alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › population

population

4 studies tagged population, dated 2009-05-06 to 2024-12-23. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Identification of circulating risk biomarkers for cognitive decline in a large community-based population in Chongqing China 2024-12-23
  2. Population pharmacokinetic-pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease 2022-09-27
  3. Potential blood biomarker for disease severity in the Taiwanese population with Alzheimer's disease 2012-12-10

Studies

4 studies carry this tag.

Date range

2009 to 2024

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • American journal of Alzheimer's disease and other dementias 1
  • CPT: pharmacometrics & systems pharmacology 1
  • Journal of neurology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Identification of circulating risk biomarkers for cognitive decline in a large community-based population in Chongqing China

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-12-23 Biomarkers

    The common and distinct risk factors across cognitive decline stages emphasize the need for tailored interventions.

  2. Population pharmacokinetic-pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. CPT: pharmacometrics & systems pharmacology 2022-09-27 Biomarkers

    Lecanemab is a humanized immunoglobulin G1 monoclonal antibody that selectively binds to soluble Aβ aggregate species, while demonstrating low affinity for Aβ monomer.

  3. Potential blood biomarker for disease severity in the Taiwanese population with Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. American journal of Alzheimer's disease and other dementias 2012-12-10 Biomarkers

    The identification of blood biomarkers for Alzheimer's disease (AD) could contribute for improvement in early diagnosis.

  4. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of neurology 2009-05-06 Biomarkers

    The clinical diagnosis of sporadic Creutzfeldt-Jakob disease (sCJD) is difficult, and reliable markers are highly desired.

All topic tags with their study counts